Among the virulence factors associated with the toxinogenic system includes them in a class of molecules designated as diseases of Staphylococcus aureus arc the staphylococcal ensuperantigens (30). Superantigens are characterized by the terotoxins (SEs). These toxins, represented by several seroability to serve as ligands simultaneously binding to major types. constitute a group of proteins that share significant histocompatibility complex (MHC) class 11 receptors on antisequence homologies in various regions of the toxin molecule gen-presenting cells as well as to T-cell receptors (TCR) which (22, 30). These cxtracellular proteins have been classically express particular VP elements. The results of this interaction recognized as mediating food poisoning characterized by emeare T-cell proliferation and cytokine secretion. The repertoire sis and diarrhea (2) .
of Vos activated has a pattern that is characteristic for each SE In addition to this distinguishing cnterotoxic property. the (0I)). SEs possess an added array of biological activities that place Attempts to define the relationship between the structure of them within a functionally and genetically related group of SEs and their various biologic activities have focused primarily pyrogcnic exotoxins whose activities impact several organ on the activation of T lymphocytes. These studies indicate that systems of susceptible hosts and contribute to clinical synmore than one region of the toxin is involved in T-cell dromcs that can culminate in lethal shock (34, 38) . These activation. Induction of T-cell proliferation was reported for an exotoxins share such activities as pyrogenicity (6. II). enhanceamino-terminal fragment of SEC (41) and for an aminoment of endotoxic shock (42), induction of immunosuppresterminal synthetic peptide of SEA (36). Another study, howsion (40l). induction of a variety of cytokines (1. 14, 39), and ever, revealed that T-cell proliferation and pyrogenicity were mitogcnesis of T cells (27, 35) . The production of cytokincs has associated with the carboxy-terminal three-quarters of SEC (4) been thought to be the cause of lethal shock by these toxins, and a 17-kDa carboxy-terminal fragment of SEB but not an but it is now apparent that other factors may also be involved amino-terminal SEB fragment (3) . Studies of chimeric mole-(23, 34, 3F). Recent studies indicate that SEB is cytotoxic to cules from genetic fusions of SEB fragments to protein A human proximal kidney cells (8) and exhibits a capacity to alter indicated that residues I to 138 were sufficient to promote platelet function and metabolism (46) . SEB can increase levels idce d th at r e res I lt i of the fi rst 30 am oof cyclooxygenase and lipo)xygcnasc metabolites of the arachi-T-cell proliferation whereas deletion of the first 311 aminodofniyclooxac acid pich mgnay montaboliteso the in ammatio, terminal residues of SEB eliminated activation of at least one donic acid pa(hway, which may contribute to inflammation.
V3 type (7) . Deletions of amino-terminal and carboxy-termiedema, and shock (5, 23. 34).
nal residues of SEA and SEB reduced their mitogenic'activity determined by using a beta counter (LKB/Wallac, GaithersSynthetic peptides and conjugates of SEB. On the basis of burg, Md.). Each experiment was performed with eight replithe published sequence of native SEB (24), a series of 13 cates, and the SEB dose response was determined with each peptides (30 amino acids long) were prepared by Peninsula experiment. Laboratories. Belmont, Calif. The series contained 15-aminoInhibition of SEB-induced proliferation by peptides or by acid overlaps between adjacent peptide sequences except for antiserum to individual peptides. (i) Peptides. To assess the the sequence region containing the disulfide loop. Peptides ability of peptides to inhibit SEB-induced proliferation, pepconjugated to keyhole limpet hemocyanin (KLH) were pretides or peptide-KLH was added to the wells containing cell pared from peptide sequences to which had been added a cultures. Then. I h later, SEB was added at a final concentralauroyl-cysteine residue at the amino-terminal end. A lauroyl tion of 0.025 l±g/ml. The cultures were incubated as described residue alone was added to peptide sequences already containin the previous section. ing cysteine at the amino-terminal end. Each lauroyl-cysteine 0ii) Antisera. Antiscra (50. 1(N). or 150 pgl) were incubated peptide was conjugated to KLH via the cysteine residue by the with 0.025 t±g of SEB and culture medium for I h at 25°C (in method of Liu et al. (28) . A 20-mg portion of peptide was a total volume of 3W(1 [tl in 24-well plates). At the end of the conjugated per 10( mg of KLH. KLH-conjugatcd peptides incubation period, each well was diluted to I ml with culture were dissolved in water at 4 mg/ml for storage of <2 months at medium, 100 f.I was added to eight replicate cell cultures -84'C (solutions were not freeze-thawed). The working conalready plated in 96-well plates, the cultures were incubated centrations ranged from 0.(5 to 11 R~g/ml (ca. 2.5 to 51(1 nM for and harvested, and proliferation was determined as above. the pcptidc). Unconjugated peptides were not readily soluble Phorbol ester-induced proliferation. Phorbol dibutyryl ester in water and were first dissolved in dimethyl sulfoxide at 4 (PDBu) (Sigma) was dissolved in dimcthyl sulfoxidc at a mg/mI and stored as described for the KLH-conjugated pepconcentration of 2 mg/ml. It was stored at -84'C in aliquots so tides.
that it would not undergo freeze-thaw cycles. The concentraPolyclonal antibodies to peptides. Peptides conjugated to tions used in proliferation assays ranged from 2 to 201 ng/ml. KLH were used to hyperimmunize rabbits to prepare polyFor experiments testing peptide inhibition of PDBu-stimulated clonal antiscra against the peptide fragments. Rabbits were proliferation, the peptides were incubated with the cell culimmunized subcutaneously with 40 R±g of peptide-conjugatc tures for I h and then PDBu. at approximately 501; maximal without adjuvants. Booster immunizations were administered 2 stimulation, was added to the cultures. and 7 weeks later. Sera were collected by bleeding from ear Inhibition of binding of . 2 .I-SEB to macrophages or lymveins 2 to 3 weeks after each immunization, and samples were phocytes. SEB was made radioactive with 5' 2 1 by using iodogcn assayed for immunoglobulin G antibody responses to native (Pierce, Rockford, III.) (29) and separated from unincorpo-SEB in an enzyme-linked immunosorbent assay (ELISA) as rated "'I by d tsaling on a G-25 Sephadex (Pharmacia, described previously (33). Titers for binding to SEB were Boston, Mass.) column (I by 30 cm) with deionized water as determined from dilut!ions of sera that gave a half-maximal the cluant. The ' 2 "I-SEB fraction was collected and dried by response in the ELISA. All antiscra prepared against peptidcvacuum centrifugation (Speed-Vac: Savant. Farmingdale. INFEc-r. IMMUN. The bars show the preparations of monocytes ( 9 9c/ purity) or lymphocvtcs (>991; purity) alone that also were incubated with SEB at were used for this determination. One was designed to achieve population of lymphocytes (99% purity) was unresponsive to filter mats, and the radioactivity incorporated was determined as SEB at 0.025 I.Lg/ml but was stimulated approximately fivefold described in Materials and Methods. over controls by 0.2 ,tg of SEB per ml. about fivefold less than the stimulation of the lymphocyte-monocytc mixture (Fig. 1) .
Monocytes alone (99% purity) showed no increase in [methyl-N.Y.). Lymphocytes (4 X 10"10.5 mi) or macrophages (2 X 3 Hlthymidine incorporation at either concentration of SEB. A 10"/0.5 ml) were incubated in a microcentrifuge tube with no ratio of monocytes to lymphocytes of 1:4 was observed to give additions, with nonradioactive SEB, or with peptide 1-30, maximal proliferation at either concentration of SEB. 9.3-112, or 130-160 at concentrations ranging from 10 to 2(X)
Inhibition of proliferation by conjugates of synthetic peptide ±g/ml; 10 min later, ' 2 1i-SEB was added at a concentration fragments of SEB. In an attempt to relate structure to function, one-fifth that of the peptides. The cell suspension was incuwe prepared overlapping peptide sequences as show:. in Table  bated for an additional I h at 4°C. The cells were centrifuged I. For the sake of discussion, the area of SEB included in these at 1,5( x g for 10 min, the supernatant solution was decanted, sequences is identified by their designation in the crystal and the cells were resuspended in 2(XW RII of phosphate-buffered structure as published by Swaminathan et al. (43). saline (PBS). Lymphocyte separation medium (diluted .0:50
Of all the peptides that were tested for stimulation of with PBS) was layered under the cell suspension and centriproliferation, only peptide 1-30 showed a two-to threefold fuged at 15,W0 X g for 10 min to separate ccll-bound from free increase over control values (data not shown). Similarly, '-[I-SEB. The supernatant solution was carefully removed peptidcs complexed with KLH were also tested to determine if (from the top), the microcentrifuge tube tip containing the cell they inhibited or enhanced SEB-induced proliferation. Bepellet was cut off, and radioactivity was determined in a gamma cause the concentration of SEB was crucial to demonstrate counter (LKB/Wallac).
inhibition or enhancement, a nonsaturable concentration was selected for these studies (0.t025 hg/ml). KLII-C0otjugdtcd RESULTS peptides (Fig. 2) were found to be the most effective in the analysis of the inhibition of SEB-induced proliferation. ProInduction of proliferation in mixtures of lymphocytes and gressive analyses of peptides representing the amino through monocytes by SEB. Cultures of human peripheral blood lymcarboxyl termini of SEB revealed the following: peptide 1-30, phocytes and monocytes were stimulated with SEB at various blockage of approximately 55% of SEB-induced proliferation: concentrations from 01.025 to 5.0 , g/ml (0.9 to 180 1 iM). Hlthymidinc (used 61-92, 50% inhibition; pcptide 93-112, 47% inhibition: and ;he as a measure of proliferation) showed that the lowest concensuccessive two peptides 103-130 and 112-144, no inhibition. (ration of SEB which consistently gave an 8-to 10-fold increase Peptide 130-160) was the most inhibitory (62%4 decreased) of above controls was 0.025 lhg/ml. Maximal stimulation (40-to this series of pcptidcs. The remaining three peptides were 51)-fold) was observed with 0.4 to I vg of SEB per ml. Higher somewhat inhibitory. concentrations of SEB (2 to I1I tpg/ml) did not significantly Peptidcs which showed significant inhibitory activity (Fig. 2 ) increased thymidinc incorporation beyond that seen at I (peptidcs 1-301. 63-92, 93-112. and 130-160) were next tested V.g/ml.
at concentrations from 0.1 to 10 Rg/ml (Fig. 3) . KLH-conjuTo determine the optimal ratio of lymphocytes to monocytcs gated peptides 1-30 and 130-160I were both effective at t0.4 for maximal response to SEB in the proliferation assay, we Rig/ml, and, taking into account the KLH molecule (8t)" of the varied the number of monocytes while keeping the number of weight), it is apparent that these SEB sequences were effective lymphocytes constant (Fig. I ) . Two concentrations of SEB at the equivalent of 20 nM for inhibition of SEB at (0.0125 R±g/ml in rabbits. Antisera to peptides reacted with native SEB (see the legend to Fig. 4) . In our tests, antisera to SEB were diluted 40-, 20-. and 12.5-fold. preincubated with SEB for I h. and added to plated cells. The three dilutions of antisera displayed incremental decreases in SEB-induced proliferation (Fig. 4) . In contrast, antiscra to KLH displayed no inhibition at even the highest concentration used (Fig. 4) . Antisera raised to i peptide 1301-1601 and sequences near it (Fig. 4) tides. The peptides were tested with another mitogen, PDBu. peripheral blood monecytes plus lymphocytes (1:4) were incubated to determine if the inhibitory effect they displayed was specific with 10 p.g of the designated peptide-KLH conjugate per ml for I h.
to SEB. PDBu was tested alone at various concentrations in SEB was added at 0.0.25 iDgwml (molar ratio of peptide to SEB. 568:i ) The cultures were incubated for 601 h. and proliferation was detercomparison with SEB. SEB and PDBu were seen to be mined as described in the legend to Fig. I . These data are the averages synergistic (Fig. 5, inset) . A concentration of PDBu at halfof three to five separate experiments with eight replicates each.
maximal stimulation was chosen, as had been done with SEB Student's I test was used to compare proliferation in the presence of (Fig. 5) . The only peptide which showed consistent inhibitioji SEB alone with that in the indicated samples. Asterisks indicate that of PDBu-induced proliferation was peptide 93-112, which the differences in the means of the samples are highly significant at the contained the linear sequence encompassing the disultide loop P = 01.015 level.
region of SEB (Fig. 6 ). Inhibition of binding of ' 2 5 -SEB by peptide conjugates. The peptides which had shown some degree of inhibition of (0.9 nM). Peptidc 151-180 was effective at 2 ýLg/ml (M10( lM), SEB-induced proliferation were examined to determine if they and peptides 61-92 and 93-112 were effective at 5 i.tg/mI (250 would interfere with binding of ' 2 51-SEB to either monocytcs nM). or lymphocytes separately. Direct iodination of peptides was Identical peptide sequences without conjugation to KLH found to present difficulties, which we avoided by using the showed a similar pattern of inhibition. The degree of inhibition pcptides as inhibitors in the same type of experiment whose was not as great as that for the KLH-conjugated peptides results are presented in Fig. 2 . We examined binding of under the conditions of our assay (data not shown).
' 25 1-SEB (4 to 64 jitg/ml: 0.296 IgCi/Rg) and inhibition of Antipeptide antiserum inhibition of proliferation. Antisera binding of ' 5 1-SEB in the presence of either nonradioactive to SEB, KLH, and each KLH-conjugated peptide were raised SEB (fivefold excess) (to determine specific binding) or conjugated peptides 1-30, 93-112. 130-160, and KLH. Each peptide was tested at concentrations ranging from 11 to 4MK) Rig/ml, with ' 25 1-SEB being approximately the same concentra--..
(tion (in micrograms per milliliter) as the peptide (KLH made up 80• of the conjugate, therefore, the molar ratio of '251-SEB to peptide was 2.2:2(1). -2 5 1-SEB specific binding to lymphocytes upon preincubation with KLH was decreased to 7% of control values (Fig. 7) . Peptide 1-3(1 showed nearly identical results to those seen with KLH (6.417/). Peptide 93-112 displayed slightly elevated inhibition (11.5%), and "peptide 130-1601 showed the greatest inhibitory effect (85%).
comparable to that seen with nonradioactive SEB (Fig. 7) . At the highest concentrations of ' residues 152 to 161) . which contains be inhibitory (Fig. 2) were incubated at various concentrations with the a highly conserved sequence in the pyrogenic exotoxins of S. cell cultures exactly as described in the legend to Fig. 2 indicated that residues in (he amino-terminal end of the toxin a synthetie peptide encoding the carboxy-terminal 41 amino (residues 9 to 23) were important in interactions with both acids of the supcrantigenic PepM5 protein of Streptococcus MHC class II and TCR (25) . In addition, the carhox~yl-terminal pyogcnes blocked PepM5-mediatcd T-cell proliferation. This region of SF8 has been associated with activity. Our data peptide contains the sequence motif similar to that described indicate significant inhibition of proliferation with different above.
pcptide conjugates encompassing residues 1901 to 195. for The three-dimensional model based on the crystal structure which (he three-dimensional position (43) is juxtaposed beside of SEB (43) would place this sequence at the bottom of a the sequence from 13 to 22. Our peptides 171-200t and 191-220 groove in the region which forms a domain functionally (near the carboxy terminus) contained those regions (Table I ) associated with both MHC class II binding (DI61. RI65) and and inhibited SEB-induced proliferation by about 411•, (Fig.  TCR binding (K152, EI59, Y162 ). Our findings that tlie 2). This region may relate more directly to similar inhibition peptide sequence from 130 to 16(0 inhibited binding of 125[-seen with the fragment from I to 3(1. This is further supported SF8 to lymphocytes concurs with this interpretation. This by the fact that antisera raised to the pcptides 1-3(1 and study did not determine selective binding of SEB to T or B 191-22(1 were completely ineffective in neutralizing SEBlymphocytes. The lack of inhibition of binding of -' 25 1-SEB to induced proliferation, whereas antiserum raised to peptide monocytes may be influenced by the absence of lymphocytes in 171-2(10t was somewhat effective. However, the pattern of the incubation mixture and may not be completely reflective of neutralizing activity, being greatest with peptides 1310-16(1 and the interaction of SEB in its role as a superantigen.
151-18(0 and gradually losing activity on either side of these Conjugates of peptides containing sequences from the amiregions. suggests that the neutralizing action of pcptide 171-no-terminal end of SEB also inhibited cell proliferation in-20(11 may relate to the initial portion of the peptidc (residue duced by native SEB. Pcptide conjugate 1-3(0 inhibited SE8 171). Construction of genetic mutants of the closely related activity by approximately 55% (Fig. 2) . Similar inhibition of toxins SEA and SEE revealed that carbox'y-tcrminal residues SEA-induced lymphocyte proliferation (36) was reported for (32). specifically residues 2016 and 2017 (20) . dictate the VI3 an equivalent amino-terminal peptide of SEA (residues I to specificity of these toxins. Pcptide 61-92 was also able to 27). Moreover, a peptide containing residues I to 45 of SEA inhibit SF8-induced proliferation. However, the overlapping eration, which suggests that the functional region involved experiments were done to see if any of the peptides were amino acid residues between 70 and 90. The structure of the synergistic with PDBu or were able to inhibit PDBu-induced TCR-binding domain identified by the crystallographic studies proliferation. Only one peptide (peptide 93-112) was able to of Swaminathan et al. (43) suggests that residues 87 to 92 may inhibit both SEB-and PDBu-stimulated proliferation. Antisera line the TCR groove. The antiserum to this peptide was not raised to that peptide were ineffective in preventing SEBable to neutralize SEB-induced proliferation, induced proliferation. In SEB, these residues make up the Phorbol esters have been used as costimulatory agents with calcium ionophores (26, 45) and can, by themselves, stimulate the appearance of a surface marker, CD69 (44), which is indicative of protein kinase C activation (45) . In this study, we found that PDBu could, by itself, stimulate a low level of was added to the cultures at 1lit the molar concentration of the peptide (to mimic the conditions described in the legend to Fig. 3 ): KLH inhibition of binding was determined at the microgram-per-FIG. 6 . Determination of iiihibition of PDBu-stimulated proliferamilliliter concentrations used for the peptide conjugates. Binding of tion by peptide fragments of SEB. Peptides were incubated with cell '25I-SEB in the presence of a fivefold excess of nonradioactive SEB cultures for I h, and PDBu was added at 25 ng/ml. Cultures were showed the specific binding to lymphocytes. After I h. the radioactivity incubated and harvested, and the significant differences were identified bound to the cells was determined as described in Materials and exactly as described in the legend to Fig. 2 .
Methods.
